PSYONIC

PSYONIC operates at the intersection of assistive technology, prosthetics, robotics, and wearable hardware. Its core differentiation is the combination of touch sensing, pressure feedback, rapid actuation, impact robustness, and compatibility with common prosthetic control systems in a single upper-limb device. The company also extends the same platform toward industrial automation, research, and humanoid robotics through its Ability Hand Robotics Platform and Open API. This gives PSYONIC a broader potential market than a conventional prosthetics manufacturer, while creating additional demands around clinical evidence, reimbursement, reliability, and integration. PSYONIC’s stated affordability and goal of minimizing out-of-pocket costs distinguish its access strategy from premium bionic-hand offerings, but the record does not provide verified pricing, reimbursement coverage, unit sales, or regulatory adoption metrics. Its participation in ABB-related robotic dexterity work suggests a developing position as a provider of human-movement and tactile-interaction technology, rather than solely as a prosthetic-device company.

PSYONIC’s trajectory shows a transition from grant-supported technical development into commercial product and robotics-platform expansion. The company was founded in 2015 and received grants totaling $2.387 million across four rounds dated 2017, 2019, 2020, and 2022. It then recorded a $1.076 million equity-crowdfunding round on April 30, 2024, followed by an unspecified seed round on October 10, 2025. The structured funding total is $3.463 million, although other available financial signals describe two 2024 crowdfunded raises totaling $7.1 million; this discrepancy limits confidence in the cumulative financing picture. Product momentum became clearer with the Ability Hand launch on May 13, 2025, followed by a robotics version, an Open API, and user and clinician support offerings. The company also tripled its staff in 2023 and was actively hiring, indicating an operational scaling phase. By June 2026, its work with ABB Robotics indicated an inflection from prosthetic commercialization toward supplying tactile and dexterity capabilities for robotics. Current employee-count precision and revenue data remain limited.